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Fucoidan was extracted from the brown seaweed Turbinaria decurrens by hot water extraction and characterized with 
HPLC, FTIR, NMR and GPC to study the impact against the White Spot Syndrome Virus (WSSV), bacteria and fungi. 
Fucoidan was fed for shrimps along with the diet (before and after WSSV infection). In the end of the study, the survival 
percentage of shrimp was 51% (in the case of 5-8 g) and 97% (in the case of 12-15 g), respectively. Among the 10 bacterial 
pathogens and 7 fungal pathogens, fucoidan inhibited 2 bacterial pathogen such as S. aureus (0.26±0.02 mm) and E. faecalis 
(1.3±0.1 mm) and A. Niger (0.84 ± 0.03 mm) in fungal pathogens with clear zone of inhibition. 
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Introduction 
WSSV is a viral disease affecting most of the 
commercially culturing marine shrimp species in the 
world. WSSV infection is characterized by a rapid 
disease on set and high mortalities. The principal 
clinical sign of WSSV is the presence of white spot 
on the carapace and the body colour of diseased 
shrimps becomes pale or reddish in colour1. Out 
breaks of WSSV causing serious mortality to cultured 
shrimp have been occurring in Asia since 1992. In 
order to prevent WSSV infection in cultured shrimp, 
the present study is planned to use the purified 
fucoidan from the brown seaweed T. decurrens.   
Fucoidan represent 40% of the dry weight of isolated 
cell walls of brown seaweeds2,3. It is composed of 
fucose, uronic acids, galactose, xylose and sulfated 
fucose4,5. They are comprised of long chains of linked 
sugar molecules, along with sulfate groups which 
make them negatively charged. They composed 
primarily of highly branched (1→2) or (1→3) linked 
α-L-fucose-4-sulfate units6.Structures and chemical 
composition of polysaccharide vary among the 
species and sometimes among different parts of the 
plant6,7. This structural complexity, chemical 
composition of fucoidan of algal origin may vary 
depending on the method of extraction8. Fucoidan 
interfere in several cellular processes such as 
migration, adhesion, proliferation and apoptosis2,9. 
Thus, each new fucoidan of algal origin has unique 
compound with unique structural features which may 
display varied bioactivity and would be a potentially a 
new drug.  
Fucoidan from algae possess important 
pharmacological activities such as antioxidant10, 
anticoagulant and antithrombotic11,12, antiproliferative, 
anti-inflammatory, antiviral13, antitumour and 
immunomodulatory14, hepatoprotective15, 
neuroprotective16. Turbinaria species have been 
reported to have wide range of pharmacological 
activites. Only limited number of studies has been 
done in Turbinaria decurrens. So, the present study 
was planned to isolate fucoidan from T. decurrens and 
to study against WSSV infection in P. monodon. 
 
Materials and Methods 
The brown seaweed T.decurrens belonging to the 
family phaeophyceae was collected in yervadi, India. 
Specimens were identified and authenticated by 
phycologist Dr.P.Anantharaman, Faculty of Marine 
Sciences, Annamalai University, Parangipettai, India. 
The collected T. decurrens was initially washed with 
seawater to remove the macroscopic epiphytes and 
other extraneous matter and then rinsed in distilled 
water. Specimen was shade dried and coarsely 
powdered. 100g of dried seaweed powder was 
depigmented with acetone followed by hot water 
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extraction at 90-95°C for 3-4 h. Brown colored syrup 
was then filtered through whatmann No.3 filter paper, 
concentrated to ¼ of the original volume, cooled and 
precipitate was centrifuged at 5000 rpm, dehydrated 
with diethyl ether and further purified in HPLC (data 
not shown) to get a sulphated polysaccharide 
fucoidan17. FT-IR spectroscopy of sulphated 
polysaccharide revealed the presence of hydrogen 
bonded compound, possible acid or amide salt, 
ionized compound and aliphatic tertiary amine salt. 
1H- NMRanalysis shows the presences of signals 
corresponding to fucose. 3 OH groups appeared at 
3.95 ppm, C= C-H (1H) (acetylenic group) signals at 
3.45 ppm, C≡C-H (1H) (methylenic proton) signals at 
2.35 ppm and 2.30 ppm C-H2 protons appeared at 
1.34 ppm (2H). Presence of these signals clearly 
indicates that the isolated polysaccharide from T. 
decurrens is fucoidan. Biochemical estimation of the 
isolated fucoidan is carbohydrate 59.62%, sulfate 
26.52%, and Uronic acid 6.3%. Molecular weight of 
the compound was determined in gel permeation 
chromatography as 2,34,000 Da16. All the chemicals 
were purchased from sigma chemical company (St. 
Louis, Mo) and Himedia (Mumbai, India).  
Healthy shrimps weighing 5 – 8 and 12 – 15 g were 
used in this study. Both groups were performed 
separately in duplicate with 15 shrimps each treatment. 
Fucoidan was fed by mixing it with shrimp diet in 100, 
200 and 400 mg/ kg (5-8 g) and 100 and 200 mg/ kg 
(12-15) of shrimp respectively. Fucoidan was fed for 4 
days before WSSV infection. The shrimp were 
challenged by incubation in the virus solution for 2 .5 h. 
This virus concentration caused the controlshrimp to die 
in 3–5 days. The fucoidan was fed continuously for 15 
days. The same diet without fucoidan was fed to the 
control groups, which were also challenged with WSSV. 
Theshrimp were monitored for 10 days after infection 
and all mortality were recorded. 
The WSSV virus solution was prepared by using 
gills, heart and lymphoid organ of WSSV-infected 
shrimp, crushed in K-199 (1% w/v M199,1.88M 
Nacl,0.06 M CaCl2·2H2O, 0.1M L-glutamine, 9.14 
mM Herpes and 10% (v/v) salt mixture which 
consists of 0.05 M KCl, 0.12 M MgSO4·7H2O, 0.16M 
MgCl2·6H2O and 3.2 mM NaH2PO4·2H2O, pH 7.3-
7.6) at1:2 (W/V). Suspension was precipitated by 
centrifugation at 3000×g for 10min; the supernatant 
fluid was then centrifuged at 8000×g, 4°C for 39 min, 
filtered through a 0.45µm membrane and stored 
in15%glycerol at -70°Cuntill used18.  
Test group of the shrimp weight was 12 – 15 g fed 
with fucoidan 200 mg/ kg of body weight and WSSV 
infected (group 3). Phagocytic activity was compared 
with that of the normal diet control (group 1) and 
WSSV infected shrimp (group2). Haemolymph (0.5 
ml) was collected on day 7 of the culture and mixed 
with 0.5 ml of KC-199 (Itami et al., 1994). 
Haemocytes were separated by centrifugation at 6500 
rpm at 4 °C, then washed with KC-199. Haemocytes 
were then suspended ~107 cells in 0.2ml and mixed 
with 0.2 ml of latex beads (~108/ml, particle diameter 
1.094µm) on a clean glass side. Mixture was 
incubated in a moisture chamber at room temperature 
for 30 min. The cells were fixed by 2.5% 
glutaraldehyde for 5 min, after which the nonadherent 
cells were removed with 0.85% NaCl, then followed 
by air-drying, and staining with Wright stain. 
Numbers of ingested cells and ingesting cells were 
counted from 200 cells and calculated for percentage 
of phagocytosis, phagocytic index (PI) and average 
number of the beads ingested per cell (ABPC) as 
follows19   
 
൬
ܲercentage 
phagocytosis൰  = ൮
number	of	cells	ingesting	beadnumber	of	cell	observed ൲	× 100 
൤
Phagocytic	index	(PI) ൨ = ൮number	of	cells	ingesting	beadnumber	of	cell	observed ൲
× ൮ number	of	bead	ingestednumber	of
	cells	observed൲ × 100 
൦
Average	number
	of	the	bead	ingested	per	cell	(ABPC)	 ൪ = ൮
number	of	bead	ingestednumber	of	cellingesting	bead൲ 
 
The antimicrobial activity of the fucoidan from T. 
decurrens was assayed using the paper disc diffusion 
method. Human pathogens were obtained from the 
Rajamuthaihah medical college, Annamalai 
University. Bacterial pathogens namely Escherichia 
coli,Aeromonas hydrophila, Staphylococcus aureus, 
Pseudomonas aeruginosa,Enterococcus faecalis, 
Enterobacter aerogenes, Micrococcus luteus, 
Salmonella typhi, Bacillus subtilis and B. megaterium 
were used to study the antibacterial activity using 
muller hinton agar medium. Fungal pathogens namely 
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Aspergillus niger, Aspergillus flavus, Penicillium sp, 
Trichoderma sp, Trichothecium sp, Hormodendrum 
spand Rhizophus sp were used to study the antifungal 
activity using potato dextrose agar medium. 1, 1.5 and 
2 mg/ml of fucoidan from T. decurrens were 
dissolved in sterile distilled water. 50µl from each 
concentration was poured into sterile filter paper discs 
(5 mm diameter) and dried for 30 min, prior to the 
inoculation. The disc was placed onto the surface of 
bacterial and fungal pathogens swabbed petriplates 
and incubated for 24-72 hours. After incubation, the 
clearance zones around the discs were measured in 
millimeters and the assays were carried out in 
triplicate. Erythromycin was used as control for 
antibacterial and nystatin for antifungal activity.  
 
Results 
Polysaccharide was extracted using hot water and 
yield of crude polysaccharide was 10.43 g/kg. The 
crude polysaccharide was precipitated with calcium 
chloride to separate fucoidan from alginates. The 
precipitated polysaccharide was partially purified in 
DEAE cellulose52 using 2M sodium chloride and the 
yield was 6.46 g/kg. The active fraction was identified 
by carbohydrate estimation using phenol sulfuric acid 
method and it was used for the further study. Partially 
purified sample was further purified in HPLC using 
C18 column and the yield was 3.38 g/kg.  
100, 200, 400 mg/kg of body weight of fucoidan 
was fed to 5-8 g and 12-15 g of shrimps before and 
after immersing in WSSV solution. Survival rate of 5-
8 g of shrimp was 5.8%, 19.3% and 61% respectively. 
In case of 12-15 g of shrimp was 54% and 97% 
survived respectively. For shrimps, which did not get 
fucoidan, 50% were dead 3 – 5 days after WSSV 
infection and 100% after 15 days. Phagocytic activity 
(Table 1) for the fucoidan fed shrimps with WSSV 
infection was found to have a higher phagocytic 
index, a higher percentage of phagocytosis and a 
higher ABPC than both of the control groups. 
Antimicrobial activity was determined in fucoidan 
from T. decurrens at 1, 1.5 and 2 mg/ml (Table 2). 
Antibacterial activity was observed at 2 mg/ml against 
S. aureus and E. faecalis with a clear zone of 
0.26±0.02 mm and 1.3±0.1 mm respectively. In 
antifungal activity clear zone of inhibition was 
observed only against A. niger at 2mg/ml with 0.84 ± 
0.03 mm. 
 
Discussion 
Viral and bacterial infections together with poor 
water quality are the main reason for shrimp 
mortality. Reinforcing resistance against the invading 
pathogens of shrimp by improving shrimp immunity 
is an acceptable strategy for defending diseases. 
Unlike the mammals and fishes, crustaceans over 
lacks a specific immune system20. Usage of natural 
immunostimulant as a better remedy than 
administrating vaccines and antibiotics is accepted for 
the control of pathogen in aquaculture. 
Among the different extraction method for 
polysaccharide, hot water extraction contributed 
higher yield17,21. The present study supports the above 
statement by providing a good yield (10.43 g/kg) of 
polysaccharide using hot water extraction. The crude 
polysaccharide was further purified in HPLC to 
isolate fucoidan and the yield was 3.38 g/kg. Due to 
the high antioxidant potential, fucoidan from 
T.decurrens showed promising activity against the 
liver damage15 and parkinsons disease16.  
Fucoidan from Cladosiphon okamuranuswas 
reported to control WSSV inP. japonicus22 and crude 
fucoidan of Sargasum polycystum was reported to 
Table 2 — Antimicrobial activity of fucoidan from T. decurrens 
S. No. Pathogens 1 mg/ml 1.5 mg/ml 2 mg/ml 
Bacterial pathogens 
1. Escherichia coli - - - 
2. Aeromonas hydrophila - - - 
3. Staphylococcus aureus - - + 
4. Pseudomonas aeruginosa - - - 
5. Enterococcus faecalis - - + 
6. Enterobacter aerogenes - - - 
7. Micrococcus luteus - - - 
8. Salmonella typhi - - - 
9. Bacillus subtilis - - - 
10. Bacillus megaterium - - - 
Fungal pathogens 
1. Aspergillus niger - - + 
2. Aspergillus flavus - - - 
3. Penicillium sp - - - 
4. Trichoderma sp - - - 
5. Trichothecium sp - - - 
6. Hormodendrum sp - - - 
7. Rhizophus sp - - - 
Table 1 — Phagocytic activity of shrimp 
Immunity indexes Group1 
(control 
shrimps) 
Group 2 
(WSSV 
infected) 
Group 3 (fed with 
fucoidan and 
WSSV infected) 
Phagocytic index (n=10) 1.2 ±0.4 0.41±0.31 3.41±1.23 
%phagocytosis (n=10) 6.27±2.43 3.63±1.32 10.4±1.98 
ABPC (n=10) 2.0±0.62 1.5±1.2 3.1±0.75 
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control WSSV in P. monodon18. Fucoidan from T. 
decurrens fed to the WSSV infected shrimps reduced 
the mortality rate in both groups (5– 8 and 12 – 15 g) 
of the experiment. Mechanism of inhibition of WSSV 
is unclear. Fucoidan from C. okamuranus was also 
reported to control WSSV in P. japonicus18,22 but the 
mechanism of the fucoidan extracted from C. 
okamuranus were not disclosed.The 26.52% sulfate of 
the Fucoidan from T. decurrens inhibited WSSV and 
the sulfate content effects on antiviral (WSSV) 
activity as previously proposed by Witvrouw & De 
Clercq23 therefore, thelower dose may be manipulated 
by hypersulfation of the fucoidan, or the fucoidan 
from other sources with a higher content of sulfate are 
needed. 
 
The cell extracts and active constituents of various 
algae have been shown to have antibacterial activity 
in vitro against Gram-positive and Gram-negative 
bacteria24. Fucoidan from T. decurrens showed 
antibacterial activity against S. aureus and E. faecalis 
and in antifungal activity A.niger with minimum zone 
of inhibition. The polysaccharide extracted from algal 
species showed a high content of sulfate, but the 
sulfate content did not show a clear relation to the 
antimicrobial activity. In contrast, Berteau and 
Mulloy2 reported that the antimicrobial activity of the 
polysaccharides was related to their chemical 
structure and ester sulfate groups. On the other hand, 
several species of brown seaweed that have a high 
sulfate content have been reported to have 
antimicrobial activities25,26. Fucoidan from macro 
algae possess antibacterial activity18,27. Crude 
fucoidan from brown algae Sargassum polycystum at 
12 mg/ml inhibited the growth of V. harveyi, S. 
aureus and E.coli which was the supportive evidence 
for the present study and the concentrations were 
higher than the present study. 
 
Conclusion 
In future Fucoidan will be as one of the 
immunostimulant which increases phagocytic activity 
of the shrimps. From this study it was concluded that 
Fucoidan from T.decurrens can be used as the 
immunostimulant and as in feed formulation to 
control WSSV in culture ponds.  
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